StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
AKBM.OL$108.00-0.37%
Fair $108.00+0.0%

AKBM.OL

Aker BioMarine ASA

Consumer Defensive / Packaged FoodsOslo

$108.00

-0.40 (-0.37%)

Fairly Valued+0.0%Fair Value $108.00Fund rank 23/100 · Data gapFallback financials|
SA 31/D
F-Score: 4/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 16%

FCF escenarios

weak_data · normalized FCF $-4.9M · quality 37.7/100

Data gap 23/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 24/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

31/100

D

Piotroski

4/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -15.8%, below the 5% threshold
Thesis & Journal · AKBM.OLLocal privado en este navegador · Aker BioMarine ASA
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$9.5B

P/E

N/A

•

EV/EBITDA

293.8x

↑

ROE

-15.8%

↓

Gross Margin

44.8%

↑

Debt/Equity

1.26

↑
52-Week Range$108
$55$118

TradingView lightweight chart

AKBM.OL price, volumen y niveles de valoración

Último $108.00Periodo +3.2%
Fair value: $108.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-7.7%

FCF CAGR

—

FCF margin

-2.2%

FCF / Net income

0.21x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $218.1M · net income $-22.8M · FCF $-4.9M

2022-FY → 2025-FY

Gross margin

44.8%+3.4% pts

Operating margin

5.9%-1.0% pts

Net margin

-10.5%-14.1% pts

FCF margin

-2.2%+8.9% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$218.1M$218.1M$199.0M$196.3M$277.2M
Net Income$-22.8M$-22.8M$182.6M$-9.0M$10.0M
EBITDA$32.8M$32.8M$38.2M$39.7M$81.9M
EPS-0.26-0.262.09-0.100.11
Gross Margin44.8%44.8%39.4%36.9%41.4%
Operating Margin5.9%5.9%-2.7%-5.3%6.9%
Net Margin-10.5%-10.5%91.8%-4.6%3.6%
Balance Sheet
Debt/Equity1.261.260.891.071.01
Current Ratio3.323.32———
Cash Flow
Free Cash Flow$-4.9M$-4.9M$-10.9M$-1.9M$-31.0M
Returns
ROE-15.8%-15.8%109.7%-2.5%2.6%
Valuation
P/E——31.24—359.09
EV/EBITDA293.82293.82153.37110.8346.66
P/B65.7765.7734.3911.009.14
Growth & Yield
Revenue Growth9.6%9.6%1.4%-29.2%—
EPS Growth-112.4%-112.4%2190.0%-190.9%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +81.8%

Total return

+81.8%

Start / end P/E

n/dx → n/dx

EPS bridge

2.09 → -0.26

Residual

+81.8%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+81.8%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.